Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
Go back to Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 0.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.87 | 52 Week High | $3.65 | |||
| Open | $0.87 | 52 Week Low | $1.24 | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.87 | EPS | $0.00 | |||
| Volume | 18 | |||||
